Neurological aspects of antiphospholipid antibody syndrome

Lupus

Volumn 5, Issue 5, 1996, Pages 347-353

  Levine, S R ^a,b   Brey, R L ^a  

^a Center for Stroke Research   (United States)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

Anticardiolipin antibody; Antiphospholipid syndrome; Chorea; Lupus anticoagulant; Migraine; Seizures; Stroke; Thrombosis; Transverse myelitis

Indexed keywords

LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; BRAIN INFARCTION; BRAIN ISCHEMIA; CAVERNOUS SINUS THROMBOSIS; CHOREA; CONFERENCE PAPER; DEMENTIA; PRIORITY JOURNAL;

EID: 0029848150     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339600500503     Document Type: Conference Paper

References (65)

1. Vila P, Hernandez MC, Lopez-Fernandez MF, Baille J. Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects. Thromb Haemostat 1994; 72: 209-213.
2. McNeil HP, Chesterman CN, Krilis SA. Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 1991; 49: 193-280.
3. Coull BM, Levine SR, Brey RL. The role of antiphospholipid antibodies and stroke. Neurol Clin 1992; 10: 125-143.
4. Feldmann E, Levine SR. Cerebrovascular disease with antiphospholipid antibodies: immune mechanisms, significance and therapeutic options Ann Neurol 1995; 37 (suppl 1): S114-S130.
5. Levine SR et al. Recurrent stroke and thrombo-occlusive events in the antiphospholipid syndrome. Ann Neurol 1995; 38: 119-124.
6. Campbell AL, Pierangeli SS, Wellhausen S, Harris EN. Comparison of the effects of anticardiolipin antibodies from patients with the antiphospholipid antibody syndrome and with syphilis on platelet activation and aggregation. Thromb Haemostat 1995; 73: 529-534.
7. Vasquez-Mellado J, Llorente L, Richaud-Patin Y, Alarcon-Segovia D. Exposure of anionic phospholipids upon platelet activation permits binding of beta-2-glycoprotein I and through it that of IgG antiphospholipid antibodies. J Autoimmunity 1994; 7: 335-348.
8. Brey RL, Levine SR. Treatment of neurologic complications of the antiphospholipid antibody syndrome. Lupus 1996; 5: 473-476.
9. Antiphospholipid Antibodies in Stroke Study (APASS) Group. Anticardiolipin antibodies are an independent risk factor for first ischemic stroke. Neurology 1993; 43: 2069-2073.
10. Camerlingo M et al. Anticardiolipin antibodies in acute non-hemorrhagic stroke seen within six hours after onset. Acta Neurol Scand 1995; 92: 60-71.
11. Brey RL, Hart RG, Sherman DG, Tegeler CT. Antiphospholipid antibodies and cerebral ischemia in young people. Neurology 1990; 40: 1190-1196.
12. Levine SR, Deegan MJ, Futrell N, Welch KMA. Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases. Neurology 1990; 40: 1190-1196.
13. Montalban J et al. Value of immunologic testing in stroke patients: a prospective multicenter study. Stroke 1994; 25: 2412-2415.
14. Ginsburg KS et al. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med 1992; 117: 997-1002.
15. Klemp P et al. Anticardiolipin antibodies in ischemic heart disease. Clin Exp Immunol 1988; 89: 411-419.
16. Ciocca RG, Choi J, Graham AM. Antiphospholipid antibodies lead to increased risk in cardiovascular surgery. Am J Surg 1995; 170: 198-200.
17. D'Olhaberriague L et al. Specificity of anticardiolipin antibodies in cardiovascular diseases. Lupus 1996 (in press).
18. The Antiphospholipid Antibodies in Stroke Study (APASS) Group. Clinical and laboratory findings in patients with antiphospholipid antibodies and cerebral ischemia. Stroke 1990; 21: 1268-1273.
19. Ford SE, Lillicrap DM, Brunet D, Ford PM. Thrombotic endocarditis and lupus anticoagulant, a pathogenetic possibility for idiopathic rheumatic type valvular heart disease. Arch Pathol Lab Med 1989; 113: 350-353.
20. Khamashta MA et al. Association of antibodies against phospholipids with valvular heart disease in patients with systemic lupus erythematosus. Lancet 1990; 335: 1541-1544.
21. Cervera R et al. High prevalence of significant heart valve lesions in patients with the 'primary' antiphospholipid antibody syndrome. Lupus 1991; 1: 43-47.
22. Badui E et al. The heart in the primary antiphospholipid syndrome. Arch Med Res 1995; 26: 115-120.
23. D'Alton JG et al. Multiple transient ischemic attacks, lupus anticoagulant and verrucous endocarditis. Stroke 1985; 16: 512-514.
24. Ford SE, Kennedy LA, Ford PM. Clinico-pathological correlations of antiphospholipid antibodies. Arch Path Lab Med 1994; 118: 491-495.
25. Levine SR et al. Antiphospholipid antibody associated stroke: prospective assessment of recurrent event risk. Stroke 1993; 24: 188.
26. Rosove MH, Brewer PMC. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992; 117: 303-308.
27. Triplett DA, Brandt JT, Musgrave KA, Orr CA. The relationship between lupus anticoagulants and antibodies to phospholipids. JAMA 1988; 259: 550-554.
28. Alarcon-Segovia D et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus: a prospective analysis of 500 consecutive patients. Medicine 1989; 68: 353-365.
29. Verro P, Levine SR, Tierjen GE. Cerebrovascular ischemic events with high positive anticardiolipin antibodies. Stroke 1995; 26: 160.
30. Escalante A, Brey RL, Mitchell BD, Dreiner U. Accuracy of anticardiolipin antibodies in identifying a history of thrombosis among patients with systemic lupus erythematosus. Am J Med 1995; 98: 559-567.
31. Carhuapoma JR, Mitsias P, Levine SR, The association of cerebral venous thrombosis with anticardiolipin antibodies. Neurology 1996; 46: A458.
32. Bokarewa MI et al. Studies on antiphospholipid antibodies. APC-resistance and associated mutation in the coagulation factor V gene. Thromb Res 1995; 78: 193-200.
33. Del Papa N et al. Relationship between antiphospholipid and antiendothelial cell antibodies III: beta-2-glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules. Clin Exp Rheum 1995; 13: 179-185.
34. Pierangeli SS, Harris EN. Antiphospholipid antibodies in an in vivo thrombosis model in mice. Lupus 1994; 3: 247-251.
35. Rafuse PE, Canny CLB. Initial identification of antinuclear antibody-negative systemic lupus erythematosus on ophthalmic examination: a case report with discussion of the ocular significance of anticardiolipin (antiphospholipid) antibodies. Can J Ophthatmol 1992; 27: 189-193.
36. Labutta RJ. Ophthalmic manifestations in the antiphospholipid syndrome. In: Asherson RA, Cervera R, Piette JC, Shoenfeld Y (eds) The Antiphospholipid Syndrome. CRC Press, 1996, 213-218, USA.
37. Kalashnikova LA, Nasonov EL, Kushekbaeva AE, Gracheva LA. Anticardiolipin antibodies in Sneddon's syndrome. Neurology 1990; 40: 464-467.
38. Sneddon IB. Cerebral vascular lesions in livedo reticularis. Br J Dermatol 1965; 77: 180-185.
39. Zelzer B et al. Sneddon's syndrome: A long term follow-up of 21 patients. Arch Dermatol 1993; 129: 437-444.
40. Coull BM et al. Multiple cerebral infarctions and dementia associated with anticardiolipin antibodies. Stroke 1987; 18: 1107-1112.
41. Schmidt R et al. Anticardiolipin antibodies in normal subjects. Neuropsychological correlates and MRI findings. Stroke 1995; 26: 749-754.
42. Tietjen GE et al. Factors which predict antiphospholipid immuno-reactivity in young people with focal neurologic deficits. Arch Neurol 1993; 50: 833-836.
43. Tietjen GE et al. Differentiating TIA from migraine aura in adults under 60 years of age. Stroke 1995; 26: 174.
44. Silvestrini M et al. Migrainous stroke and the antiphospholipid antibodies. Eur Neurol 1994; 34: 316-319.
45. Tietjen GE, unpublished data, personal communication, 1996.
46. Herranz MT et al. Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. Arthritis Rheum 1994; 37: 586-571.
47. Inzelberg R, Korczyn AD. Lupus anticoagulant and late onset seizures. Acta Neurol Scand 1989; 79: 114-118.
48. Levine SR, Welch KMA. The spectrum of neurologic disease associated with antiphospholipid antibodies: lupus anticoagulants and anticardiolipin antibodies. Arch Neurol 1987; 44: 876-883.
49. Liou HH et al. Anticardiolipin antisera from lupus patients with seizures reduce a gaba receptor-medicated chloride current in snail neurons. Life Sciences 1994; 54: 1119-1125.
50. Kent M, Vogt E, Rote NS Monoclonal antiphospholipid antibodies react directly with cat brain. Lupus 1994; 3: 315.
51. Yeh TS et al. The study of anticardiolipin antibodies and interleukin-6 in cerebrospinal fluid and blood of Chinese patients with systemic lupus erythematosus and central nervous system involvement. Autoimmunity 1994; 18: 169-175.
52. Brey RL, Cote S, Teale JM. Neurological dysfunction and autoantibody-producing B cells from brain in a lupus-prone mouse strain. Neurology 1993; 44: 1420.
53. Asherson RA, Hughes GRV. Antiphospholipid antibodies and chorea. J Rheumatal 1988; 15: 377-379.
54. Hatron PY et al. Chorea, systemic lupus erythematosus, circulating lupus anticoagulants. J Rheumatol 1987; 14: 991-993.
55. Furie R, Ishikawa T, Dhawan V, Eidelberg D. Alternating hemichorea in primary antiphospholipid syndrome: evidence for contralateral striatal metabolism. Neurology 1994; 44: 2197-2199.
56. Montalban J et al. Transient global amnesia and antiphospholipid antibodies. Clin Exp Rheumatol 1989; 7: 85-87.
57. Harris EN et al. Lupoid sclerosis: a possible pathogenic role for antiphospholipid antibodies. Ann Rheum Dis 1985; 44: 281-283.
58. Lavalle C et al. Transverse myelitis: a manifestation of systemic lupus erythematosus associated with antiphospholipid antibodies. J Rheumatol 1990; 17: 34-37.
59. Jackson C et al. Anticardiolipin antibodies in Guillain-Barre Syndrome. Clin Exp Rheumatol 1992; 10: 657.
60. Harris EN et al. Antiphospholipid antibodies in acute guillam-bane syndrome. Lancet 1983; 2: 1361-1362.
61. Maes M et al. Antiphospholipid antibody, epstein barr and cytomegalovirus antibodies and interleukin-2 receptors in depressive patients. J Affective Dis 1991; 21: 133-140.
62. Molad Y et al. Lupus anticoagulant correlation with magnetic resonance imaging of brain lesions. J Rheumatol 1992; 19: 556-561.
63. Provenzale JM et al. Antiphospholipid antibodies in patients without systemic lupus erythematosus: neuroradiologic findings. Radiology 1994; 192: 531-537.
64. Toubi E, Khamashta MA, Panarra A, Hughes GRV. Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus. Am J Med 1995; 99: 397-401.
65. D'Olhaberriague L, Levine SR, Tietjen GE, Aurora T. Embolism is the most likely mechanism of stroke related to antiphospholipid antibodies. Neurology 1996; 46: 459.